Skip to content


    Embracing Flexibility and Innovation to Modernize Clinical Trial Analytics and Reporting

    October 13, 2022

    Save Your Spot

    SCE Transformation through the Lens of GSK

    As companies modernize their processes and technologies supporting clinical development, much of the focus is on statistical computing environments (SCEs) for clinical trial data analytics. Statistical computing environments (SCEs) are not a new concept, but there has been a shift in how the problem is being approached and how solutions are being designed. 
    GSK recently conducted a large-scale clinical modernization program, and Eileen Ching has led the effort for Biostatistics to modernize statistical programming and data science, with studies now being delivered in the new solution. Caroline Phares has worked with Eileen, both as her technology partner at GSK and now continues to support her as Domino’s Head of Health and Life Sciences.
    Join Eileen and Caroline as they reflect on the challenges, lessons learned, and unexpected delights along this journey of transformation, from solution design through to production implementation and execution of live studies. You will:

    • Understand the challenges to be expected when undertaking a change of this magnitude
    • Learn best practices when designing and implementing new processes
    • Discover how the Domino platform operates at the heart of a modern and future-proof SCE solution

    Meet the Speakers
    Eileen Ching
    Director of Clinical Programming, Research & Development, GSK

    Eileen Ching is a seasoned and versatile leader with decades of experience in the pharmaceutical industry. In addition to delivering clinical trials reporting efforts and drug submissions, she has successfully led global teams to develop and deliver strategies enabling drug research and development, leveraging her breadth of skills such as statistical programming, software development, project management, process improvement, service management, and technology implementation. She is passionate about transforming the traditional clinical data analysis and reporting processes with technology, data, analytics, and process optimization.

    She is currently the Business Lead of a large-scale multi-year program to implement a modern data science platform and deliver transformational changes to GSK R&D Biostatistics. She holds a bachelor’s degree in Computer Science from University of Pennsylvania, a master’s degree in Software Engineering from Pennsylvania State University, and an MBA from Temple University.
    Caroline Phares
    Head of Health and Life Sciences, Domino Data Lab

    Caroline Phares leads the Health and Life Sciences strategy for Domino Data Lab. Prior to Domino, she enjoyed 20 years of success at GSK as a business partner and technology leader in designing, delivering, and supporting innovative solutions across R&D. During her time at GSK, she was involved in collaborative efforts with other large pharmaceutical companies and has influenced industry trends in technology solutions to common problems and use cases. She is driven to pursue and implement positive, transformational change through scientific and technological progress, and enjoys applying modern tools and methodologies to problems which may have once seemed unsolvable.

    Don’t miss your opportunity to learn from these incredible industry leaders

    Save Your Seat